Telix Pharmaceuticals Limited (TLX) said that it has submitted its Biologics License Application (BLA) to the U.S. Food and Drug ...

TLX250-CDx is an investigational PET 3 drug product for the non-invasive diagnosis and characterization of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer ...

Some research supports statin use for people with kidney disease or kidney failure and heart disease. Other research recommends caution for those with kidney issues. Heart disease is a major cause ...

In November 2023, Lupin Ltd. unveiled the world’s first fixed-dose triple combination drug for managing chronic obstructive pulmonary disease (COPD). In October 2023, Glenmark Pharmaceuticals ...

Anemia is more common in later-stage chronic kidney disease (CKD), with diabetes and dialysis increasing the risk. Treating the underlying cause can improve symptoms and quality of life.

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $468.09, demonstrating a +0.94% swing from the preceding day's closing price. This change outpaced the S&P 500's 0.38% gain on the ...

Today, we discuss the innovative way a mother is attempting to raise money for a gene therapy for her child, we see South African regulators drop their investigation into Vertex’s cystic ...

Vertex Pharmaceuticals (Vertex) is a biotechnology company that ... It uses state-of-the-art technology platforms to discover new disease targets, compounds, delivery mechanisms, and treatment ...

Inaxaplin is under development for the treatment of APO-L1 mediated kidney diseases including focal segmental glomerulosclerosis (FSGS). The drug candidate is administered through oral route. It acts ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

HELSINKI, Dec 12 (Reuters) - The European Medicines Agency (EMA) will allow Novo Nordisk (NOVOb.CO), opens new tab to add risk reduction for events related to kidney disease to the label of its ...